Form 4 for BSX Boston Scientific
Accepted 2026-02-17 00:00:00 ET · period of report 2026-02-12 · accession 0001225208-26-002020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-17 | 2026-02-12 | BSX | Woodworth Emily | SVP, CAO, Gbl Ctrl | M - OptEx | $0.00 | +481 | 1,193 | +68% | $0 |
| D | 2026-02-17 | 2026-02-12 | BSX | Woodworth Emily | SVP, CAO, Gbl Ctrl | F - Tax | $74.12 | -242 | 951 | -20% | -$17.9K |
| DM | 2026-02-17 | 2026-02-12 | BSX | Woodworth Emily | SVP, CAO, Gbl Ctrl | A - Grant | $0.00 | +11.7K | 5,584 | New | $0 |
| D | 2026-02-17 | 2026-02-12 | BSX | Woodworth Emily | SVP, CAO, Gbl Ctrl | M - OptEx | $0.00 | -481 | 962 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-12 | M | A | 481 | $0.00 | 1,193 | D | — | — | (F1) Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. (F2) Includes shares acquired on June 30, 2025 under the Company's Employee Stock Purchase Plan based upon the most current data available. |
| 2 | Common | Common Stock | 2026-02-12 | F | D | 242 | $74.12 | 951 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2026-02-12 | A | A | 6,071 | $0.00 | 6,071 | D | — · — to 2030-02-12 | 6,071 Common Stock | (F1) Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. (F4) Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant. |
| 4 | Derivative | Restricted Stock Units | 2026-02-12 | M | D | 481 | $0.00 | 962 | D | — · — to 2028-02-12 | 481 Common Stock | (F1) Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. (F3) Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-02-12 | A | A | 5,584 | $0.00 | 5,584 | D | $74.12 · — to 2036-02-12 | 5,584 Common Stock | (F5) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant. |